abstract |
The present invention provides a compound of formula I as a TRPC5 modulator: Novel thieno- and furo [2,3-d] pyrimidine-2,4 [1H, 3H] -dione derivatives and uses thereof, pharmaceutical compositions containing said derivatives and treatment of TRPC5 receptor-mediated diseases or conditions It relates to a method of using the pharmaceutical composition as a pharmaceutical agent. A, R 1 , R 2 , R 3 and R 4 have a predetermined meaning in the specification. |